Join the 200th Anniversary Celebration

Original Article

Brief Report

Bilateral Spreading Cerebral Hypoperfusion during Spontaneous Migraine Headache

Roger P. Woods, Marco Iacoboni, and John C. Mazziotta

N Engl J Med 1994; 331:1689-1692December 22, 1994

Article

Although decreases in regional cerebral blood flow are known to occur in relation to migraine headache, the pattern of the alterations in blood flow has not been precisely delineated. Olesen et al. have described a series of patients who had migraine headaches during serial cerebral blood-flow measurement by the intracarotid xenon-133 technique.1 They observed a pattern of localized decreases in flow that appeared to spread contiguously along the cerebral cortex. These observations were confirmed in subsequent studies,2,3 and with very few exceptions1,4 the pattern of “spreading oligemia” or “spreading hypoperfusion”5 has been apparent only in patients who have migraine headaches with aura (previously known as classic migraine).6 The carotid-artery puncture itself was thought to trigger the migraines in these patients,2 causing concern about the generalizability of these findings to spontaneous migraines7.

Areas of hypoperfusion have been demonstrated tomographically with intravenous or inhaled xenon-133 in patients who rushed to the hospital at the onset of spontaneous migraine headaches,6 but no subsequent spreading of the area of hypoperfusion has been demonstrated, possibly because these patients were studied much later in the course of their headaches. As a general rule, the hypoperfusion is ipsilateral to the headache pain and contralateral to the symptoms of aura.3 Two unexplained cases of bilateral blood-flow changes have been documented3.

Although the presence of hypoperfusion in migraine with aura is well accepted, the spreading nature of the hypoperfusion is controversial, since some investigators argue that the apparent spread is a technical artifact8,9. During a recent series of blood-flow measurements with positron-emission tomography (PET) and oxygen-15-labeled water, one of our subjects unexpectedly had a migraine headache. The headache was associated with bilateral hypoperfusion that started in the occipital lobes and spread anteriorly into the temporal and parietal lobes, providing unequivocal high-resolution evidence of the spreading nature of hypoperfusion associated with a spontaneous migraine.

Case Report

A 21-year-old right-handed woman was recruited as a normal volunteer for the PET study of cerebral blood flow. As an adult, she had had headaches every one to two weeks, some of which were unilateral and associated with nausea, vomiting, or photophobia. Motion or glare from a computer terminal could cause or aggravate her headaches. She had never had migraine with aura or neurologic deficits, and she had no neurologic deficits before, during, or after the PET study. The only other family member with headache was a cousin who had migraines.

The woman gave informed consent in accordance with the requirements of the UCLA Human Subjects Protection Committee. Twelve serial measurements of blood flow were made at 15-minute intervals with the subject in a darkened room, fixating her vision on a computer screen that presented a series of line drawings at a rate of two per second. A few minutes after the sixth measurement, she noted the gradual onset of a throbbing headache that she described as a sharp pain in the center of the back of her head, “as if someone had hit me there.” The headache worsened, with no change in location, during the six subsequent measurements. She also had nausea and photophobia. Interviewed after the study about any symptoms that might be interpreted as those of a migraine with aura, she indicated that during one measurement (the ninth, she thought) she had been unable to focus her vision clearly on the drawings on the screen, although she tried very hard to concentrate on doing so. She indicated that otherwise she had looked fixedly at the screen with her eyes open throughout all the measurements.

The subject continued to have headache, nausea, mild vertigo, and anorexia after returning home from the study and had headache and nausea for the entire next day, before her condition gradually returned to base line.

Methods

For each measurement of blood flow, the subject received an intravenous injection of 10 mCi (370 MBq) of water labeled with oxygen-15. Data were acquired for two minutes after the injection. As compared with shorter imaging times, this approach improves the signal-to-noise ratio but results in a nonlinear relation between blood flow and counts.10-12 Three different sets of visual stimuli -- A, B, and C -- were presented in the order ABCCBAABCCBA during the study. The subject was instructed to view these stimuli passively, maintaining visual fixation on a cross in the center of the screen. Visual fixation was verified immediately before and after each measurement.

The scanning procedures and image-reconstruction methods have been described by Cherry et al13,14. Each final data set consisted of 15 planes with a distance of 6.75 mm between planes and a full width at half-maximal resolution of 7.2 mm within the plane and 7.5 mm axially. Correction was made for minor head movements.15 The PET images were registered to T1-weighted magnetic resonance imaging (MRI) scans as described by Woods et al16.

Data analysis began with simple visual inspection of the images. The subject's headache began after the sixth measurement, and large changes in blood flow unrelated to the visual stimuli were obvious in all six measurements made after the onset of headache. Because these changes spared the frontal and inferior cerebellar regions, the images were normalized to one another on the assumption that blood flow to these regions remained constant throughout all 12 measurements; the global normalization process generally used in analyzing PET activation studies was not applied.17 After normalization, the first five sets of images were averaged to create a pre-headache base-line image (the sixth set of images, acquired immediately before the onset of the headache, was not included). This base-line image was then compared with each subsequent measurement to generate a series of images indicating the percentage of change.

The subdivisions of the images (voxels) that were of potential interest were those in which the blood flow was lowest and decreased the most (to a level at least 20 percent below the base-line value) in studies 7 through 12. To eliminate areas of noise, only the largest contiguous region of voxels that met these criteria was analyzed further. Six regions of interest that were not necessarily contiguous were generated within this larger region by categorizing each voxel according to the measurement obtained after the onset of headache that showed the greatest sequential decrease in blood flow. These six regions were used to generate time-activity profiles that included all 12 measurements. Finally, the Pearson correlation coefficient18 was used to reclassify each voxel meeting the above criteria according to the time-activity profile with which it had the strongest positive significant correlation, with P values less than 0.005 considered to indicate statistical significance.

Results

Figure 1Figure 1PET and MRI Scans of Blood Flow in the Brain of a Woman with Migraine Headache. shows the base-line set of images obtained before the headache, the images showing the percentages of change in measurements 6 through 12, and the corresponding MRI images. Figure 2Figure 2Time-Activity Profiles for the Six Regions of Interest in the Areas with Maximal Serial Decreases in Regional Blood Flow during Measurements 7 through 12. shows a graph and a series of anatomical images; the colors used to depict the six time-activity profiles on the graph correspond to the colors used on the images to depict the areas significantly correlated with the various time-activity profiles.

Discussion

Bilateral decreases in blood flow were evident in our subject's occipital regions in the first measurement after the onset of the headache (i.e., the seventh measurement), and the decreases progressed anteriorly with time. Although certain strong neurophysiologic stimuli can produce blood-flow changes of the magnitude seen here,19,20 the subject's blood-flow changes were unrelated to the stimuli presented, and these same stimuli have produced blood-flow changes of only about 5 percent in other volunteers. Eye closure can cause decreased occipital blood flow, but the subject indicated that she was consistently able to maintain visual fixation despite the headache. The earliest blood-flow changes did not involve the primary visual cortex and so cannot be attributed to eye closure. Given the tomographic nature of the images and the relatively high spatial resolution, we see no basis for dismissing the changes as methodologic or physiologic artifacts. The involvement spread contiguously across the cortical surface at a relatively constant rate, sparing the cerebellum, the basal ganglia, and the thalamus and ultimately spanning the vascular distributions of four major cerebral arteries.

Given that extensive serotonergic afferent neurons from nuclei of the median and dorsal raphe supply the small blood vessels of the brain,21,22 we considered the possibility that the changes we observed in cortical blood flow might have been mediated neuronally through projections from these nuclei. However, evidence from a study of macaques suggests that projections from the median raphe have almost no topographic relation to the cortical surface.23 This lack of a cortical topographic relation is difficult to reconcile with a causative role for these nuclei in generating the organized pattern of blood-flow changes seen in our subject, but it does not exclude a serotonergic role in transducing the physiologic changes associated with migraine into pain24.

We believe that the most plausible explanation for the blood-flow changes in our subject is that they were the result of spreading depression. Spreading depression, first described by Leao,25 is a transient marked reduction in electrical activity in gray matter in animals that advances contiguously across the cortical surface; the rate of advance is consistent with the spread of symptoms during migraine with aura26,27. It is associated with decreases in blood flow similar in magnitude and duration to those measured here.28-30 The hypothesis of spreading depression in migraine has recently been reviewed elsewhere.31 Spreading depression can move transcallosally to homologous regions of the opposite hemisphere in animals,25,26,32 and we postulate that transcallosal spread accounts for the bilaterality of the findings in our subject. The regions involved earliest were the visual areas known as Brodmann's areas 18 and 19, which are known to have interhemispheric connections through the corpus callosum33,34. Although unilaterality of headache is one of the criteria used in diagnosing migraine,35 bilateral migraines with aura are well documented7,36,37.

Because of our imaging protocol, the decrements in counts that we measured systematically underestimated the actual decrements in blood flow. We estimate that the actual maximal decreases were on the order of 40 percent, potentially approaching the ischemic range. However, most of these extreme changes were relatively brief, with substantial recovery by the time of the next measurement 15 minutes later. Whether the symptoms of migraine with aura are caused by ischemia is a controversial question38,39 that cannot be addressed in this case because of the paucity of symptoms of aura in our subject. Her hazy vision, characterized by Olesen as a “less typical” aura symptom, has not generally been associated with blood-flow abnormalities in previous studies.5 A better understanding of the pathophysiologic features of spreading hypoperfusion would be of obvious clinical importance, since migraine can sometimes lead to ischemic stroke and since stroke can sometimes be aggravated by or associated with the development of migraine40.

Supported by a grant (1 K08 NS01646-01) from the National Institute of Neurological Disorders and Stroke, a contract (DE-FCO3-87ER60615) with the Department of Energy, gifts from the Ahmanson Foundation and the Jennifer Jones Simon Foundation, and grants from the International Human Frontier Science Program and the Brain Mapping Medical Research Organization.

We are indebted to the volunteer who participated in this study for her extraordinary cooperation; to Deborah Dorsey, R.N., for recruiting the subject; to Diane Martin for photography; to Ron Sumida, Larry Pang, Marc Hulgan, and Der-Jen Liu for technical assistance during the PET study; and to Dr. Simon Cherry for the three-dimensional PET-reconstruction algorithm and for helpful discussions of issues related to the quantitation of the blood-flow changes.

Source Information

From the Division of Brain Mapping, Neuropsychiatric Institute (R.P.W., M.I., J.C.M.), and the Departments of Neurology (R.P.W., M.I., J.C.M.), Psychology (M.I.), Pharmacology (J.C.M.), and Radiology (J.C.M.), UCLA School of Medicine, Los Angeles.

Address reprint requests to Dr. Woods at the Department of Neurology, UCLA School of Medicine, 710 Westwood Plaza, Los Angeles, CA 90024.

References

References

  1. 1

    Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981;9:344-352
    CrossRef | Web of Science | Medline

  2. 2

    Lauritzen M, Skyhoj Olsen T, Lassen NA, Paulson OB. Changes in regional cerebral blood flow during the course of classic migraine attacks. Ann Neurol 1983;13:633-641
    CrossRef | Web of Science | Medline

  3. 3

    Olesen J, Friberg L, Skyhoj Olsen T, et al. Timing and topography of cerebral blood flow, aura, and headache during migraine attacks. Ann Neurol 1990;28:791-798
    CrossRef | Web of Science | Medline

  4. 4

    Gelmers HJ. Common migraine attacks preceded by focal hyperemia and parietal oligemia in the rCBF pattern. Cephalalgia 1982;2:29-32
    CrossRef | Web of Science | Medline

  5. 5

    Olesen J. Hemodynamics. In: Olesen J, Tfelt-Hansen P, Welch KMA, eds. The headaches. New York: Raven Press, 1993:209-22.

  6. 6

    Lauritzen M, Olesen J. Regional cerebral blood flow during migraine attacks by Xenon-133 inhalation and emission tomography. Brain 1984;107:447-461
    CrossRef | Web of Science | Medline

  7. 7

    Raskin NH. Headache. 2nd ed. New York: Churchill Livingstone, 1988.

  8. 8

    Olsen TS. Spreading oligemia in the migraine aura -- most likely an artifact due to scattered radiation. Cephalalgia 1993;13:86-88
    CrossRef | Web of Science | Medline

  9. 9

    Friberg L, Olsen TS, Roland PE, Lassen NA. Focal ischaemia caused by instability of cerebrovascular tone during attacks of hemiplegic migraine: a regional cerebral blood flow study. Brain 1987;110:917-934
    CrossRef | Web of Science | Medline

  10. 10

    Volkow ND, Mullani N, Gould LK, Adler SS, Gatley SJ. Sensitivity of measurements of regional brain activation with oxygen-15-water and PET to time of stimulation and period of image reconstruction. J Nucl Med 1991;32:58-61
    Web of Science | Medline

  11. 11

    Cherry SR, Woods RP, Mazziotta JC. Improved signal-to-noise in activation studies by exploiting the kinetics of oxygen-15 labelled water. In: Uemura K, Lassen NA, Jones T, Kanno I, eds. Quantification of brain function: tracer kinetics and image analysis in brain PET. Amsterdam: Excerpta Medica, 1993:79-85.

  12. 12

    Raichle ME, Martin WR, Herscovitch P, Mintun MA, Markham J. Brain blood flow measured with intravenous H215O. II. Implementation and validation. J Nucl Med 1983;24:790-798
    Web of Science | Medline

  13. 13

    Cherry SR, Dahlbom M, Hoffman EJ. Evaluation of a 3D reconstruction algorithm for multi-slice PET scanners. Phys Med Biol 1992;37:779-790
    CrossRef | Web of Science | Medline

  14. 14

    Cherry SR, Woods RP, Hoffman EJ, Mazziotta JC. Improved detection of focal cerebral blood flow changes using three-dimensional positron emission tomography. J Cereb Blood Flow Metab 1993;13:630-638
    CrossRef | Web of Science | Medline

  15. 15

    Woods RP, Cherry SR, Mazziotta JC. Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr 1992;16:620-633
    CrossRef | Web of Science | Medline

  16. 16

    Woods RP, Mazziotta JC, Cherry SR. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993;17:536-546
    CrossRef | Web of Science | Medline

  17. 17

    Mazziotta JC, Huang SC, Phelps ME, Carson RE, MacDonald NS, Mahoney K. A noninvasive positron computed tomography technique using oxygen-15-labeled water for the evaluation of neurobehavioral task batteries. J Cereb Blood Flow Metab 1985;5:70-78
    CrossRef | Web of Science | Medline

  18. 18

    Press WH, Teukolsky SA, Vetterling WT, Flannery BP. Numerical recipes in C: the art of scientific computing. 2nd ed. Cambridge, England: Cambridge University Press, 1992.

  19. 19

    Fox PT, Raichle ME. Stimulus rate dependence of regional cerebral blood flow in human striate cortex, demonstrated by positron emission tomography. J Neurophysiol 1984;51:1109-1120
    Web of Science | Medline

  20. 20

    Grafton ST, Woods RP, Mazziotta JC, Phelps ME. Somatotopic mapping of the primary motor cortex in humans: activation studies with cerebral blood flow and positron emission tomography. J Neurophysiol 1991;66:735-743
    Web of Science | Medline

  21. 21

    Reinhard JF Jr, Liebmann JE, Schlosberg AJ, Moskowitz MA. Serotonin neurons project to small blood vessels in the brain. Science 1979;206:85-87
    CrossRef | Web of Science | Medline

  22. 22

    Edvinsson L, Degueurce A, Duverger D, MacKenzie ET, Scatton B. Central serotonergic nerves project to the pial vessels of the brain. Nature 1983;306:55-57
    CrossRef | Web of Science | Medline

  23. 23

    Wilson MA, Molliver ME. The organization of serotonergic projections to cerebral cortex in primates. Neuroscience 1991;44:555-570
    CrossRef | Web of Science | Medline

  24. 24

    Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 1993;13:1167-1177
    Web of Science | Medline

  25. 25

    Leao AAP. Spreading depression of activity in the cerebral cortex. J Neurophysiol 1944;7:359-390
    Web of Science

  26. 26

    Leao AAP, Morison RS. Propagation of spreading cortical depression. J Neurophysiol 1945;8:33-45
    Web of Science

  27. 27

    Lashley KS. Patterns of cerebral integration indicated by the scotomas of migraine. Arch Neurol Psychiatr 1941;46:331-339
    Web of Science

  28. 28

    Lauritzen M, Jorgensen MB, Diemer NH, Gjedde A, Hansen AJ. Persistent oligemia of rat cerebral cortex in the wake of spreading depression. Ann Neurol 1982;12:469-474
    CrossRef | Web of Science | Medline

  29. 29

    Fabricius M, Lauritzen M. Transient hyperemia succeeds oligemia in the wake of cortical spreading depression. Brain Res 1993;602:350-353
    CrossRef | Web of Science | Medline

  30. 30

    Piper RD, Lambert GA, Duckworth JW. Cortical blood flow changes during spreading depression in cats. Am J Physiol 1991;261:H96-H102
    Web of Science | Medline

  31. 31

    Lauritzen M. Pathophysiology of the migraine aura: the spreading depression theory. Brain 1994;117:199-210
    CrossRef | Web of Science | Medline

  32. 32

    Marshall WH. Spreading cortical depression of Leao. Physiol Rev 1959;39:239-279
    Web of Science | Medline

  33. 33

    Zeki S. A vision of the brain. Oxford, England: Blackwell Scientific, 1993.

  34. 34

    Clarke S, Miklossy J. Occipital cortex in man: organization of callosal connections, related myelo- and cytoarchitecture, and putative boundaries of functional visual areas. J Comp Neurol 1990;298:188-214
    CrossRef | Web of Science | Medline

  35. 35

    Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988;8:Suppl 7:1-96
    CrossRef | Web of Science | Medline

  36. 36

    Gowers WR. Subjective sensations of sight and sound, abiotrophy, and other lectures. Philadelphia: P. Blakiston's Son, 1904.

  37. 37

    Sacks OW. Migraine: understanding a common disorder. Berkeley: University of California Press, 1985.

  38. 38

    Skyhoj Olsen T, Friberg L, Lassen NA. Ischemia may be the primary cause of the neurologic deficits in classic migraine. Arch Neurol 1987;44:156-161
    Web of Science | Medline

  39. 39

    Dalgaard P, Kronborg D, Lauritzen M. Migraine with aura, cerebral ischemia, spreading depression, and compton scatter. Headache 1991;31:49-53
    CrossRef | Web of Science | Medline

  40. 40

    Olesen J, Friberg L, Skyhoj Olsen T, et al. Ischaemia-induced (symptomatic) migraine attacks may be more frequent than migraine-induced ischaemic insults. Brain 1993;116:187-202
    CrossRef | Web of Science | Medline

Citing Articles (197)

Citing Articles

  1. 1

    Ana I Oliveira-Ferreira, Maren KL Winkler, Clemens Reiffurth, Denny Milakara, Johannes Woitzik, Jens P Dreier. (2012) Spreading depolarization, a pathophysiological mechanism of stroke and migraine aura. Future Neurology 7:1, 45-64
    CrossRef

  2. 2

    Lars Edvinsson, Mattias Linde. (2012) CGRP antagonists for the treatment of migraine: rationale and clinical data. Clinical Investigation 2:1, 73-88
    CrossRef

  3. 3

    Jin-Young Chung, Manho Kim. (2012) Migraine-like Headache in a Patient with Complement 1 Inhibitor Deficient Hereditary Angioedema. Journal of Korean Medical Science 27:1, 104
    CrossRef

  4. 4

    Lavinia Dinia, Laura Bonzano, Beatrice Albano, Cinzia Finocchi, Massimo Del Sette, Laura Saitta, Lucio Castellan, Carlo Gandolfo, Luca Roccatagliata. (2012) White Matter Lesions Progression in Migraine with Aura: A Clinical and MRI Longitudinal Study. Journal of Neuroimagingno-no
    CrossRef

  5. 5

    Nancy E. Kelley, Deborah E. Tepper. (2012) Rescue Therapy for Acute Migraine, Part 1: Triptans, Dihydroergotamine, and Magnesium. Headache: The Journal of Head and Face Painno-no
    CrossRef

  6. 6

    Jakob M. Hansen, Henrik W. Schytz, Vibeke A. Larsen, Helle K. Iversen, Messoud Ashina. (2011) Hemiplegic Migraine Aura Begins With Cerebral Hypoperfusion: Imaging in the Acute Phase. Headache: The Journal of Head and Face Pain 51:8, 1289-1296
    CrossRef

  7. 7

    Ju-Hong Min, Hyung-Min Kwon, Hyunwoo Nam. (2011) The effect of propranolol on cerebrovascular reactivity to visual stimulation in migraine. Journal of the Neurological Sciences 305:1-2, 136-138
    CrossRef

  8. 8

    Stefano Viola, Paolo Viola, Pasqualino Litterio, Maria Pia Buongarzone, Luisa Fiorelli. (2011) “Prolonged” migraine aura: New information on underlying mechanisms. Translational Neuroscience 2:2, 101-105
    CrossRef

  9. 9

    Giorgio Lambru, Gian Camillo Manzoni, Paola Torelli, Ilaria Grisendi, Carla Zanferrari. (2011) Reversible Cerebral Vasoconstriction Phenomena Following Indomethacin Administration. Headache: The Journal of Head and Face Pain 51:5, 813-818
    CrossRef

  10. 10

    Peer C. Tfelt-Hansen, Peter J. Koehler. (2011) One Hundred Years of Migraine Research: Major Clinical and Scientific Observations From 1910 to 2010. Headache: The Journal of Head and Face Pain 51:5, 752-778
    CrossRef

  11. 11

    Mohammad S. Asghar, Adam E. Hansen, Faisal M. Amin, R. J. van der Geest, Patrick van der Koning, Henrik B. W. Larsson, Jes Olesen, Messoud Ashina. (2011) Evidence for a vascular factor in migraine. Annals of Neurology 69:4, 635-645
    CrossRef

  12. 12

    Jens P Dreier. (2011) The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nature Medicine 17:4, 439-447
    CrossRef

  13. 13

    C. González Mingot, S. Santos Lasaosa, C. García Arguedas, L. Ballester Marco, J.A. Mauri Llerda. (2011) Migralepsia, una entidad controvertida. Neurología 26:2, 120-122
    CrossRef

  14. 14

    Pari N. Shams, Gordon T. Plant. (2011) Migraine-like Visual Aura Due to Focal Cerebral Lesions: Case Series and Review. Survey of Ophthalmology 56:2, 135-161
    CrossRef

  15. 15

    Leslie Kelman. (2011) The biological basis of headache. Expert Review of Neurotherapeutics 11:3, 363-378
    CrossRef

  16. 16

    Fengpeng Li, Enchao Qiu, Zhao Dong, Ruozhuo Liu, Shiwen Wu, Shengyuan Yu. (2011) Protection of flunarizine on cerebral mitochondria injury induced by cortical spreading depression under hypoxic conditions. The Journal of Headache and Pain 12:1, 47-53
    CrossRef

  17. 17

    Mark W. Green. (2011) Headaches: Psychiatric Aspects. Neurologic Clinics 29:1, 65-80
    CrossRef

  18. 18

    Sook Hee Cho, Myung Ho Jeong, Doo Sun Sim, Young Joon Hong, Hyung Wook Park, Ju Han Kim, Youngkeun Ahn, Jeong Gwan Cho, Jong Chun Park, Jung Chaee Kang. (2011) Diagnostic Value of Nitroglycerin-Induced Headache as a Negative Predictor of Coronary Atherosclerosis. Chonnam Medical Journal 47:1, 14
    CrossRef

  19. 19

    C. González Mingot, S. Santos Lasaosa, C. García Arguedas, L. Ballester Marco, J.A. Mauri Llerda. (2011) Migralepsy; a controversial entity. Neurología (English Edition) 26:2, 120-122
    CrossRef

  20. 20

    Yusuke SHIMODA, Kohsuke KUDO, Satoshi KURODA, Yuri ZAITSU, Nobuyuki FUJIMA, Satoshi TERAE, Makoto SASAKI, Kiyohiro HOUKIN. (2011) Susceptibility-weighted Imaging and Magnetic Resonance Angiography during Migraine Attack: A Case Report. Magnetic Resonance in Medical Sciences 10:1, 49-52
    CrossRef

  21. 21

    Hans C. Diener, Tobias Kurth. 2011. Migraine and Stroke. , 720-733.
    CrossRef

  22. 22

    Zaza Katsarava, Christian Weimar. (2010) Migraine and stroke. Journal of the Neurological Sciences 299:1-2, 42-44
    CrossRef

  23. 23

    Peer Carsten Tfelt-Hansen. (2010) Verisimilitude (or “truthlikeness”) as an alternative to pro and cons: migraine and cluster headache mechanisms. The Journal of Headache and Pain 11:5, 379-389
    CrossRef

  24. 24

    John Phillips, Neil Longridge, Arthur Mallinson, Gordon Robinson. (2010) Migraine and Vertigo: A Marriage of Convenience?. Headache: The Journal of Head and Face Pain 50:8, 1362-1365
    CrossRef

  25. 25

    Ozge Yilmaz-Kusbeci, Nuket Gocmen-Mas, Aylin Yucel, Hamit S. Karabekir, Tolga Ertekin, Ayse C. Yazici. (2010) Evaluation of Cerebellar and Cerebral Volume in Migraine with Aura: A Stereological Study. The Cerebellum 9:3, 345-351
    CrossRef

  26. 26

    KC Brennan, Andrew Charles. (2010) An update on the blood vessel in migraine. Current Opinion in Neurology 23:3, 266-274
    CrossRef

  27. 27

    Yuji Kato, Nobuo Araki, Hiroshi Matsuda, Yasuo Ito, Chihiro Suzuki. (2010) Arterial spin-labeled MRI study of migraine attacks treated with rizatriptan. The Journal of Headache and Pain 11:3, 255-258
    CrossRef

  28. 28

    Till Sprenger, Peter J. Goadsby. (2010) What has functional neuroimaging done for primary headache … and for the clinical neurologist?. Journal of Clinical Neuroscience 17:5, 547-553
    CrossRef

  29. 29

    Katharina Eikermann-Haerter, Cenk Ayata. (2010) Cortical Spreading Depression and Migraine. Current Neurology and Neuroscience Reports 10:3, 167-173
    CrossRef

  30. 30

    Lars Edvinsson, Tony W. Ho. (2010) CGRP receptor antagonism and migraine. Neurotherapeutics 7:2, 164-175
    CrossRef

  31. 31

    Hans-Christoph Diener. (2010) Single-pulse transcranial magnetic stimulation: a new way to treat migraine attacks with aura. The Lancet Neurology 9:4, 335-337
    CrossRef

  32. 32

    A. May. (2010) Das Fenster zur Kopfschmerzforschung. Der Schmerz 24:2, 130-136
    CrossRef

  33. 33

    Cenk Ayata. (2010) Cortical Spreading Depression Triggers Migraine Attack: Pro. Headache: The Journal of Head and Face Pain 50:4, 725-730
    CrossRef

  34. 34

    Andrew Charles. (2010) Does Cortical Spreading Depression Initiate a Migraine Attack? Maybe Not . . .. Headache: The Journal of Head and Face Pain 50:4, 731-733
    CrossRef

  35. 35

    Pierre Boutouyrie, Robert Corvisier, Kim-Than Ong, Claire Vulser, Catherine Lassalle, Michel Azizi, Brigitte Laloux, Stéphane Laurent. (2010) Acute and chronic effects of acupuncture on radial artery: A randomized double blind study in migraine. Artery Research 4:1, 7-14
    CrossRef

  36. 36

    Turgay Dalkara, Ala Nozari, Michael A Moskowitz. (2010) Migraine aura pathophysiology: the role of blood vessels and microembolisation. The Lancet Neurology 9:3, 309-317
    CrossRef

  37. 37

    Michael Bjørn Russell. (2010) Management of sporadic and familial hemiplegic migraine. Expert Review of Neurotherapeutics 10:3, 381-387
    CrossRef

  38. 38

    Ala Nozari, Ergin Dilekoz, Inna Sukhotinsky, Thor Stein, Katharina Eikermann-Haerter, Christina Liu, Yumei Wang, Matthew P. Frosch, Christian Waeber, Cenk Ayata, Michael A. Moskowitz. (2010) Microemboli may link spreading depression, migraine aura, and patent foramen ovale. Annals of Neurology 67:2, 221-229
    CrossRef

  39. 39

    Pasquale Montagna, Giulia Pierangeli, Pietro Cortelli. (2010) The Primary Headaches as a Reflection of Genetic Darwinian Adaptive Behavioral Responses. Headache: The Journal of Head and Face Pain 50:2, 273-289
    CrossRef

  40. 40

    Antonella Conte, Piero Barbanti, Vittorio Frasca, Elisa Iacovelli, Maria Gabriele, Elena Giacomelli, Cinzia Aurilia, Floriana Pichiorri, Francesca Gilio, Maurizio Inghilleri. (2010) Differences in short-term primary motor cortex synaptic potentiation as assessed by repetitive transcranial magnetic stimulation in migraine patients with and without aura. PAIN 148:1, 43-48
    CrossRef

  41. 41

    ME Wolf, T Jäger, H Bäzner, M Hennerici. (2009) Changes in functional vasomotor reactivity in migraine with aura. Cephalalgia 29:11, 1156-1164
    CrossRef

  42. 42

    Vinod Kumar Gupta. (2009) CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine. Expert Review of Neurotherapeutics 9:11, 1595-1614
    CrossRef

  43. 43

    CGH Dahlöf, AW Hauge, J Olesen. (2009) Efficacy and safety of tonabersat, a gap-junction modulator, in the acute treatment of migraine: a double-blind, parallel-group, randomized study. Cephalalgia 29, 7-16
    CrossRef

  44. 44

    FM Cutrer. (2009) New information in our evolving understanding of migraine aura and cortical spreading depression. Cephalalgia 29:10, 1129-1131
    CrossRef

  45. 45

    A Charles, KC Brennan. (2009) Cortical spreading depression-new insights and persistent questions. Cephalalgia 29:10, 1115-1124
    CrossRef

  46. 46

    PC Tfelt-Hansen. (2009) History of migraine with aura and cortical spreading depression from 1941 and onwards. Cephalalgia
    CrossRef

  47. 47

    GE Tietjen. (2009) Migraine as a systemic vasculopathy. Cephalalgia 29:9, 987-996
    CrossRef

  48. 48

    (2009) Posterior hypoperfusion in migraine without aura?. Cephalalgia
    CrossRef

  49. 49

    (2009) LETTER TO THE EDITOR. Cephalalgia
    CrossRef

  50. 50

    Lyudmila V. Vinogradova, Galina D. Kuznetsova, Antonius M.L. Coenen. (2009) Unilateral cortical spreading depression induced by sound in rats. Brain Research 1286, 201-207
    CrossRef

  51. 51

    MC Kruit, MA van Buchem, LJ Launer, GM Terwindt, MD Ferrari. (2009) Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia
    CrossRef

  52. 52

    Carl Dahlöf, Hans-Christoph Diener. (2009) Migraine: an endemic disease inside the blood–brain barrier. Future Neurology 4:4, 405-420
    CrossRef

  53. 53

    JH Kim, S Kim, S-I Suh, S-B Koh, K-W Park, K Oh. (2009) Interictal metabolic changes in episodic migraine: a voxel-based FDG-PET study. Cephalalgia
    CrossRef

  54. 54

    Pasquale Parisi. (2009) Why is migraine rarely, and not usually, the sole ictal epileptic manifestation?. Seizure 18:5, 309-312
    CrossRef

  55. 55

    Todd J Schwedt, David W Dodick. (2009) Advanced neuroimaging of migraine. The Lancet Neurology 8:6, 560-568
    CrossRef

  56. 56

    Y-H Cha, H Lee, LS Santell, RW Baloh. (2009) Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia 29:5, 550-555
    CrossRef

  57. 57

    Andrew Charles. (2009) Advances in the basic and clinical science of migraine. Annals of Neurology 65:5, 491-498
    CrossRef

  58. 58

    Kyu-Hyun Park, Hak-Jin Kim, Sun-Yong Baek, Byung-Mann Cho, Tae-Woo Yoo. (2009) Effect of Acupuncture on Blood Flow Velocity and Volume in Common Carotid and Vertebral Arteries in Migraine Patients. Medical Acupuncture 21:1, 47-54
    CrossRef

  59. 59

    J Wolthausen, S Sternberg, C Gerloff, A May. (2009) Are cortical spreading depression and headache in migraine causally linked?. Cephalalgia 29:2, 244-249
    CrossRef

  60. 60

    Geoffrey A. Lambert, Alessandro S. Zagami. (2009) The Mode of Action of Migraine Triggers: A Hypothesis. Headache: The Journal of Head and Face Pain 49:2, 253-275
    CrossRef

  61. 61

    Cynthia C. Bamford, Stewart J. Tepper. (2009) Daily pharmacologic prophylaxis of episodic migraine. Techniques in Regional Anesthesia and Pain Management 13:1, 20-27
    CrossRef

  62. 62

    Zaza Katsarava, Kasja Rabe, Hans-Christoph Diener. (2008) From migraine to stroke. Internal and Emergency Medicine 3:S1, 9-16
    CrossRef

  63. 63

    Flavio Devetag Chalaupka. (2008) Reversible Imaging Abnormalities Consistent With CSD During Migraine Without Aura Attack. Headache: The Journal of Head and Face Pain 48:8, 1229-1232
    CrossRef

  64. 64

    J.M. Pollock, A.R. Deibler, J.H. Burdette, R.A. Kraft, H. Tan, A.B. Evans, J.A. Maldjian. (2008) Migraine Associated Cerebral Hyperperfusion with Arterial Spin-Labeled MR Imaging. American Journal of Neuroradiology 29:8, 1494-1497
    CrossRef

  65. 65

    M Denuelle, N Fabre, P Payoux, F Chollet, G Geraud. (2008) Posterior cerebral hypoperfusion in migraine without aura. Cephalalgia 28:8, 856-862
    CrossRef

  66. 66

    Ferdinando Maggioni, Edoardo Mampreso, Silvia Ruffatti, Federica Viaro, Viviana Lunardelli, Giorgio Zanchin. (2008) Migralepsy: Is the Current Definition Too Narrow?. Headache: The Journal of Head and Face Pain 48:7, 1129-1132
    CrossRef

  67. 67

    Donald R. Nixdorf, Ana M. Velly, Aurelio A. Alonso. (2008) Neurovascular Pains: Implications of Migraine for the Oral and Maxillofacial Surgeon. Oral and Maxillofacial Surgery Clinics of North America 20:2, 221-235
    CrossRef

  68. 68

    R. Allan Purdy. (2008) Migraine with and without aura share the same pathogenic mechanisms. Neurological Sciences 29:S1, 44-46
    CrossRef

  69. 69

    David W. Dodick. (2008) Examining the Essence of Migraine—Is it the Blood Vessel or the Brain? A Debate. Headache: The Journal of Head and Face Pain 48:4, 661-667
    CrossRef

  70. 70

    Nouchine Hadjikhani. (2008) Relevance of cortical thickness in migraine sufferers. Expert Review of Neurotherapeutics 8:3, 327-329
    CrossRef

  71. 71

    D Magis, L Bendtsen, PJ Goadsby, A May, M Sánchez del Rio, PS Sandór, H Kaube, G Sandrini, GG Schoonman, J Schoenen, . (2007) Evaluation and proposal for optimization of neurophysiological tests in migraine: Part 2—neuroimaging and the nitroglycerin test. Cephalalgia 27:12, 1339-1359
    CrossRef

  72. 72

    MB Vincent, N Hadjikhani. (2007) Migraine aura and related phenomena: beyond scotomata and scintillations. Cephalalgia 27:12, 1368-1377
    CrossRef

  73. 73

    TJ Schwedt. (2007) Serotonin and migraine: the latest developments. Cephalalgia 27:11, 1301-1307
    CrossRef

  74. 74

    D Parain, A Hitzel, E Guegan-Massardier, A Lebas, C Blondeau, I Fédina, D Feray, P Véra, B Mihout. (2007) Migraine aura lasting 1?24h in children: a sequence of EEG slow-wave abnormalities vs. vascular events. Cephalalgia 27:9, 1043-1049
    CrossRef

  75. 75

    Seymour Solomon, Brian M Grosberg, Deborah I Friedman, Richard B Lipton. (2007) Retinal Migraine. Journal of Neuro-Ophthalmology 27:3, 243-244
    CrossRef

  76. 76

    Lars Edvinsson. (2007) Novel migraine therapy with calcitonin gene-regulated peptide receptor antagonists. Expert Opinion on Therapeutic Targets 11:9, 1179-1188
    CrossRef

  77. 77

    Gretchen E, Tietjen MD. (2007) Migraine and ischaemic heart disease and stroke: potential mechanisms and treatment implications. Cephalalgia 27:8, 981-987
    CrossRef

  78. 78

    Kevin C. Brennan, Marcela Romero-Reyes, Héctor E. López Valdés, Arthur P. Arnold, Andrew C. Charles. (2007) Reduced threshold for cortical spreading depression in female mice. Annals of Neurology 61:6, 603-606
    CrossRef

  79. 79

    Giovanni Merlino, Mariarosaria Valente, Sebastiano D'Anna, Gian Luigi Gigli. (2007) Seizures With Prolonged EEG Abnormalities During an Attack of Migraine Without Aura. Headache: The Journal of Head and Face Pain 47:6, 919-922
    CrossRef

  80. 80

    OD San-Juan, PF Zermeño. (2007) Migraine with persistent aura in a Mexican patient: case report and review of the literature. Cephalalgia 27:5, 456-460
    CrossRef

  81. 81

    F Michael Cutrer, Karina Huerter. (2007) Migraine Aura. The Neurologist 13:3, 118-125
    CrossRef

  82. 82

    Bumin Degirmenci, Mehmet Yaman, Alpay Haktanir, Ramazan Albayrak, Murat Acar. (2007) Cerebral and cerebellar ADC values during a migraine attack. Neuroradiology 49:5, 419-426
    CrossRef

  83. 83

    Michael A. Moskowitz. (2007) Pathophysiology of Headache?Past and Present. Headache: The Journal of Head and Face Pain 47:s1, S58-S63
    CrossRef

  84. 84

    Alexandre F.M. DaSilva, Cristina Granziera, David S. Tuch, Josh Snyder, Maurice Vincent, Nouchine Hadjikhani. (2007) Interictal alterations of the trigeminal somatosensory pathway and periaqueductal gray matter in migraine. NeuroReport 18:4, 301-305
    CrossRef

  85. 85

    Nina Marshall, William A. Maclaurin, George Koulouris. (2007) MRA Captures Vasospasm in Fatal Migrainous Infarction. Headache: The Journal of Head and Face Pain 47:2, 280-283
    CrossRef

  86. 86

    Stephen D. Silberstein, William B. Young. 2007. Headache and Facial Pain. , 1245-1266.
    CrossRef

  87. 87

    Ertan Yetkin, Handan Ozisik, Cemal Ozcan, Yuksel Aksoy, Hasan Turhan. (2007) Increased Dilator Response to Nitrate and Decreased Flow-Mediated Dilatation in Migraineurs. Headache: The Journal of Head and Face Pain 47:1,
    CrossRef

  88. 88

    CHRISTIAN SPIES, RAINER SCHRÄDER. (2006) Transcatheter Closure of Patent Foramen Ovale in Patients with Migraine Headache. Journal of Interventional Cardiology 19:6, 552-557
    CrossRef

  89. 89

    2006. Diabetic Nephropathy. .
    CrossRef

  90. 90

    Curtis P. Schreiber. (2006) The Pathophysiology of Migraine. Disease-a-Month 52:10, 385-401
    CrossRef

  91. 91

    Jean Schoenen. (2006) Future Preventive Therapy: Are There Promising Drug Targets?. Headache Currents 3:5-6, 108-111
    CrossRef

  92. 92

    A. May. (2006) A review of diagnostic and functional imaging in headache. The Journal of Headache and Pain 7:4, 174-184
    CrossRef

  93. 93

    (2006) Future Preventive Therapy: Are There Promising Drug Targets?. Headache Currents 3:5, 108-111
    CrossRef

  94. 94

    M. Linde. (2006) Migraine: a review and future directions for treatment. Acta Neurologica Scandinavica 114:2, 71-83
    CrossRef

  95. 95

    Anna S Cohen, Peter J Goadsby. (2006) Functional neuroimaging of primary headache disorders. Expert Review of Neurotherapeutics 6:8, 1159-1171
    CrossRef

  96. 96

    F. Michael Cutrer, David F. Black. (2006) Imaging Findings of Migraine. Headache: The Journal of Head and Face Pain 46:7, 1095-1107
    CrossRef

  97. 97

    Margarita Sanchez-del-Rio, Uwe Reuter, Michael A Moskowitz. (2006) New insights into migraine pathophysiology. Current Opinion in Neurology 19:3, 294-298
    CrossRef

  98. 98

    Shazia K. Afridi, Peter J. Goadsby. (2006) Neuroimaging of migraine. Current Pain and Headache Reports 10:3, 221-224
    CrossRef

  99. 99

    Tobias Kurth, Hans-Christoph Diener. (2006) Current views of the risk of stroke for migraine with and migraine without aura. Current Pain and Headache Reports 10:3, 214-220
    CrossRef

  100. 100

    Ertan Yetkin, Handan Ozisik, Cemal Ozcan, Yuksel Aksoy, Hasan Turhan. (2006) Decreased endothelium-dependent vasodilatation in patients with migraine: a new aspect to vascular pathophysiology of migraine. Coronary Artery Disease 17:1, 29-33
    CrossRef

  101. 101

    Anne Ducros. (2006) Physiopathologie et approche g??n??tique de la migraine. CNS Drugs 20:Supplement 1, 1???11
    CrossRef

  102. 102

    Katharina Haerter, Cenk Ayata, Michael A. Moskowitz. (2005) Cortical Spreading Depression: A Model for Understanding Migraine Biology and Future Drug Targets. Headache Currents 2:5, 97-103
    CrossRef

  103. 103

    Marie-Germaine Bousser, K Michael A Welch. (2005) Relation between migraine and stroke. The Lancet Neurology 4:9, 533-542
    CrossRef

  104. 104

    Lars Edvinsson, Rolf Uddman. (2005) Neurobiology in primary headaches. Brain Research Reviews 48:3, 438-456
    CrossRef

  105. 105

    MOHSEN SHARIFI, MAJID DEHGHANI, MAHSHID MEHDIPOUR, OMAR AL-BUSTAMI, FARNAZ EMRANI, JAMES BURKS. (2005) Intense Migraines Secondary to Percutaneous Closure of Atrial Septal Defects. Journal of Interventional Cardiology 18:3, 181-183
    CrossRef

  106. 106

    Hans-Christoph Diener. (2005) Headache. Current Opinion in Neurology 18:3, 279-282
    CrossRef

  107. 107

    H. C. Diener, T. Kurth. (2005) Migraine as a Risk Factor for White Matter Lesions, Silent Infarctions, and Ischemic Stroke: The Potential Mechanisms and Therapeutic Implications. Headache Currents 2:3, 53-57
    CrossRef

  108. 108

    Gretchen E. Tietjen. (2005) Migraine as a Risk Factor for White Matter Lesions, Silent Infarctions, and Ischemic Stroke. Headache Currents 2:3, 71-75
    CrossRef

  109. 109

    HR Jager, NJ Giffin, PJ Goadsby. (2005) Diffusion- and perfusion-weighted MR imaging in persistent migrainous visual disturbances. Cephalalgia 25:5, 323-332
    CrossRef

  110. 110

    Anna S. Cohen, Peter J. Goadsby. (2005) Functional neuroimaging of primary headache disorders. Current Pain and Headache Reports 9:2, 141-146
    CrossRef

  111. 111

    G Relja, A Granato, M Ukmar, G Ferretti, RM Antonello, M Zorzon. (2005) Persistent aura without infarction: decription of the first case studied with both brain SPECT and perfusion MRI. Cephalalgia 25:1, 56-59
    CrossRef

  112. 112

    Margarita Sánchez del Rio, Juan Alvarez Linera. (2004) Functional neuroimaging of headaches. The Lancet Neurology 3:11, 645-651
    CrossRef

  113. 113

    Laszlo Mechtler. (2004) Role of neuroimaging in our understanding of the pathogenesis of primary headaches. Current Pain and Headache Reports 8:5, 404-409
    CrossRef

  114. 114

    J. Olesen, H. C. Diener, J. Schoenen, J. Hettiarachchi. (2004) No effect of eletriptan administration during the aura phase of migraine. European Journal of Neurology 11:10, 671-677
    CrossRef

  115. 115

    Massimo Leone. (2004) Chronic cluster headache: New and emerging treatment options. Current Pain and Headache Reports 8:5, 347-352
    CrossRef

  116. 116

    Andrew A. Parsons. (2004) Cortical spreading depression: Its role in migraine pathogenesis and possible therapeutic intervention strategies. Current Pain and Headache Reports 8:5, 410-416
    CrossRef

  117. 117

    Deacon E. Harle, Bruce J. W. Evans. (2004) The optometric correlates of migraine. Ophthalmic and Physiological Optics 24:5, 369-383
    CrossRef

  118. 118

    Massimo Leone. (2004) Cluster headache: from vascular theories to brain therapy. Expert Review of Neurotherapeutics 4:4, 563-567
    CrossRef

  119. 119

    Thomas N Ward, Morris Levin. (2004) Diagnosis and pathophysiology of migraine. Expert Review of Neurotherapeutics 4:3, 383-390
    CrossRef

  120. 120

    Sonja Potrebic. (2004) The changing face of migraine. Current Pain and Headache Reports 8:2, 85-90
    CrossRef

  121. 121

    Anna S. Cohen, Peter J. Goadsby. (2004) Functional neuroimaging of primary headache disorders. Current Neurology and Neuroscience Reports 4:2, 105-110
    CrossRef

  122. 122

    Stephen D Silberstein. (2004) Migraine. The Lancet 363:9406, 381-391
    CrossRef

  123. 123

    H.C. Diener, K.M.A. Welch, J.P. Mohr. 2004. Migraine and Stroke. , 629-640.
    CrossRef

  124. 124

    M Ito, N Adachi, F Nakamura, T Koyama, T Okamura, M Kato, K Kanemoto, T Nakano, M Matsuura, S Hara. (2004) Characteristics of postictal headache in patients with partial epilepsy. Cephalalgia 24:1, 23-28
    CrossRef

  125. 125

    Guruswami Arunagiri, Shanmugam Santhi. (2003) Migraine: an ophthalmologist's perspective. Current Opinion in Ophthalmology 14:6, 344-352
    CrossRef

  126. 126

    M Vincent, E Pedra, J Mourao-Miranda, Ie Bramati, Ar Henrique, J Moll. (2003) Enhanced interictal responsiveness of the migraineous visual cortex to incongruent bar stimulation: a functional MRI visual activation study. Cephalalgia 23:9, 860-868
    CrossRef

  127. 127

    David E Rex, Jeffrey Q Ma, Arthur W Toga. (2003) The LONI Pipeline Processing Environment. NeuroImage 19:3, 1033-1048
    CrossRef

  128. 128

    Tobias Leniger, Sandra von den Driesch, Katrin Isbruch, Hans Christoph Diener, Andreas Hufnagel. (2003) Clinical Characteristics of Patients With Comorbidity of Migraine and Epilepsy. Headache: The Journal of Head and Face Pain 43:6, 672-677
    CrossRef

  129. 129

    SK Aurora, KMA Welch, F Al-Sayed. (2003) The threshold for phosphenes is lower in migraine. Cephalalgia 23:4, 258-263
    CrossRef

  130. 130

    Chiaki Yokota, Hiroyasu Inoue, Yuji Kuge, Takeo Abumiya, Masafumi Tagaya, Yasuhiro Hasegawa, Norimasa Ejima, Nagara Tamaki, Kazuo Minematsu. (2003) Cyclooxygenase-2 Expression Associated With Spreading Depression in a Primate Model. Journal of Cerebral Blood Flow & Metabolism395-398
    CrossRef

  131. 131

    Pamela Blake, Britta Johnson, John W. VanMeter. (2003) Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT): Clinical Applications. Journal of Neuro-Ophthalmology 23:1, 34-41
    CrossRef

  132. 132

    Phillip E. Kunkler, Richard P. Kraig. (2003) Hippocampal spreading depression bilaterally activates the caudal trigeminal nucleus in rodents. Hippocampus 13:7, 835-844
    CrossRef

  133. 133

    K.M.A. Welch. 2003. Migraine Mechanisms. , 160-163.
    CrossRef

  134. 134

    EM Bednarczyk, DS Wack, MY Kassab, K Burch, K Trinidad, M Haka, J Gona. (2002) Brain blood flow in the nitroglycerin (GTN) model of migraine: measurement using positron emission tomography and transcranial Doppler. Cephalalgia 22:9, 749-757
    CrossRef

  135. 135

    A Gutschalk. (2002) Multimodal functional imaging of prolonged neurological deficits in a patient suffering from familial hemiplegic migraine. Neuroscience Letters 332:2, 115-118
    CrossRef

  136. 136

    Robert F. Saul. (2002) Ophthalmologic migraine. Current Neurology and Neuroscience Reports 2:5, 432-435
    CrossRef

  137. 137

    C. Créac’h, B. Laurent. (2002) Apport de l’imagerie fonctionnelle cérébrale dans la physiopathologie de la migraine. Douleur et Analgésie 15:3, 131-136
    CrossRef

  138. 138

    David Rubin, Gary N. McAbee, Lori B. Feldman-Winter. (2002) Auditory Hallucinations Associated With Migraine. Headache: The Journal of Head and Face Pain 42:7, 646-648
    CrossRef

  139. 139

    Chiaki Yokota, Yuji Kuge, Yasuhiro Hasegawa, Masafumi Tagaya, Takeo Abumiya, Norimasa Ejima, Nagara Tamaki, Takenori Yamaguchi, Kazuo Minematsu. (2002) Unique Profile of Spreading Depression in a Primate Model. Journal of Cerebral Blood Flow & Metabolism835-842
    CrossRef

  140. 140

    Mark D. Reploeg, Joel A. Goebel. (2002) Migraine-associated Dizziness: Patient Characteristics and Management Options. Otology & Neurotology 23:3, 364-371
    CrossRef

  141. 141

    Wood, Alastair J.J., , Goadsby, Peter J., Lipton, Richard B., Ferrari, Michel D., . (2002) Migraine — Current Understanding and Treatment. New England Journal of Medicine 346:4, 257-270
    Full Text

  142. 142

    Dara G. Jamieson, Richard Hargreaves. (2002) The Role of Neuroimaging in Headache. Journal of Neuroimaging 12:1, 42-51
    CrossRef

  143. 143

    PA Kowacs, EJ Piovesan, MC Lange, LC Werneck, CE Tatsui, LC Ribas, L Scapucin, LEA Marques, ATR Moreira. (2001) Prevalence and clinical features of migraine in a population of visually impaired subjects in Curitiba, Brazil. Cephalalgia 21:9, 900-905
    CrossRef

  144. 144

    Stewart J. Tepper, Alan Rapoport, Fred Sheftell. (2001) The Pathophysiology of Migraine. The Neurologist 7:5, 279-286
    CrossRef

  145. 145

    M Lauritzen. (2001) Cortical spreading depression in migraine. Cephalalgia 21:7, 757-760
    CrossRef

  146. 146

    Michael F. James, Justin M. Smith, Simon J. Boniface, Christopher L-H. Huang, Ronald A. Leslie. (2001) Cortical spreading depression and migraine: new insights from imaging?. Trends in Neurosciences 24:5, 266-271
    CrossRef

  147. 147

    Peter J. Goadsby. (2001) Neuroimaging in headache. Microscopy Research and Technique 53:3, 179-187
    CrossRef

  148. 148

    Jens P. Dreier, Gabor Petzold, Katrin Tille, Ute Lindauer, Guy Arnold, Uwe Heinemann, Karl M. Einhaupl, Ulrich Dirnagl. (2001) Ischaemia triggered by spreading neuronal activation is inhibited by vasodilators in rats. The Journal of Physiology 531:2, 515-526
    CrossRef

  149. 149

    Peter J. Barbour, John E. Castaldo, Elliot I. Shoemaker. (2001) Hemiplegic Migraine During Pregnancy: Unusual Magnetic Resonance Appearance With SPECT Scan Correlation. Headache: The Journal of Head and Face Pain 41:3, 310-316
    CrossRef

  150. 150

    Lars Edvinsson. (2001) Pathophysiology of primary headaches. Current Pain and Headache Reports 5:1, 71-78
    CrossRef

  151. 151

    Egilius L.H. Spierings. (2001) Daily Migraine With Visual Aura Associated With an Occipital Arteriovenous Malformation. Headache: The Journal of Head and Face Pain 41:2, 193-197
    CrossRef

  152. 152

    J. Bank. (2001) Migraine With Aura After Administration of Sublingual Nitroglycerin Tablets. Headache: The Journal of Head and Face Pain 41:1, 84-87
    CrossRef

  153. 153

    M. Kallela, M. Wessman, M. Farkkila. (2001) Validation of a migraine-specific questionnaire for use in family studies. European Journal of Neurology 8:1, 61-66
    CrossRef

  154. 154

    Peter James Goadsby. (2001) Migraine, aura, and cortical spreading depression: Why are we still talking about it?. Annals of Neurology 49:1, 4-6
    CrossRef

  155. 155

    Aj Shepherd. (2000) Visual contrast processing in migraine. Cephalalgia 20:10, 865-880
    CrossRef

  156. 156

    K.H.J. Bockhorst, J.M. Smith, M.I. Smith, D.P. Bradley, G.C. Houston, T.A Carpenter, L.D. Hall, N.G. Papadakis, A.A. Parsons, C.L.-H. Huang, M.F. James. (2000) A quantitative analysis of cortical spreading depression events in the feline brain characterized with diffusion-weighted MRI. Journal of Magnetic Resonance Imaging 12:5, 722-733
    CrossRef

  157. 157

    Kma Welch, Nt Mathew, P Stone, W Rosamond, J Saiers, D Gutterman. (2000) Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia 20:8, 687-695
    CrossRef

  158. 158

    A Gasbarrini, M Gabrielli, G Fiore, M Candelli, F Bartolozzi, A De Luca, F Cremonini, F Franceschi, C Di Campli, A Armuzzi, V Ojetti, M Serricchio, R Pola, G Gasbarrini, M Giacovazzo, P Pola. (2000) Association between Helicobacter pylori cytotoxic type I CagA-positive strains and migraine with aura. Cephalalgia 20:6, 561-565
    CrossRef

  159. 159

    MI Smith, SJ Read, WN Chan, M Thompson, AJ Hunter, N Upton, AA Parsons. (2000) Repetitive cortical spreading depression in a gyrencephalic feline brain: inhibition by the novel benzoylamino-benzopyran SB-220453. Cephalalgia 20:6, 546-553
    CrossRef

  160. 160

    Alyssa M. OʼFarrell, David E. Rex, Arpitha Muthialu, Nader Pouratian, Greg K. Wong, Andrew F. Cannestra, James W. Y. Chen, Arthur W. Toga. (2000) Characterization of optical intrinsic signals and blood volume during cortical spreading depression. NeuroReport 11:10, 2121-2125
    CrossRef

  161. 161

    Gary McAbee, Allison Sagan, Lori Winter. (2000) Olfactory Hallucinations During Migraine in an Adolescent With an MRI Temporal Lobe Lesion. Headache: The Journal of Head and Face Pain 40:7, 592-594
    CrossRef

  162. 162

    Scott Friedenberg, David W. Dodick. (2000) Migraine-Associated Seizure: A Case of Reversible MRI Abnormalities and Persistent Nondominant Hemisphere Syndrome. Headache: The Journal of Head and Face Pain 40:6, 487-490
    CrossRef

  163. 163

    Sheena K. Aurora, K. M.A. Welch. (2000) Migraine: imaging the aura. Current Opinion in Neurology 13:3, 273-276
    CrossRef

  164. 164

    Yuji Kuge, Yasuhiro Hasegawa, Chiaki Yokota, Kazuo Minematsu, Naoto Hashimoto, Yoshihiro Miyake, Takenori Yamaguchi. (2000) Effects of single and repetitive spreading depression on cerebral blood flow and glucose metabolism in cats: a PET study. Journal of the Neurological Sciences 176:2, 114-123
    CrossRef

  165. 165

    Robert A Avery, I.George Zubal, Rik Stokking, Colin Studholme, Maria Corsi, John P Seibyl, Susan S Spencer. (2000) Decreased cerebral blood flow during seizures with ictal SPECT injections. Epilepsy Research 40:1, 53-61
    CrossRef

  166. 166

    Nicholas J. Delva, Salinda A. Horgan, Emily R. Hawken. (2000) Valproate Prophylaxis for Migraine Induced by Selective Serotonin Reuptake Inhibitors. Headache: The Journal of Head and Face Pain 40:3, 248-251
    CrossRef

  167. 167

    SL McColl, F Wilkinson. (2000) Visual contrast gain control in migraine: measures of visual cortical excitability and inhibition. Cephalalgia 20:2, 74-84
    CrossRef

  168. 168

    SJ Read, MI Smith, AJ Hunter, N Upton, AA Parsons. (2000) SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat. Cephalalgia 20:2, 92-99
    CrossRef

  169. 169

    R Luciani, D Carter, L Mannix, M Hemphill, M Diamond, R Cady. (2000) Prevention of migraine during prodrome with naratriptan. Cephalalgia 20:2, 122-126
    CrossRef

  170. 170

    Kj Werhahn, K Wiseman, J Herzog, S Forderreuther, , A Straube. (2000) Motor cortex excitability in patients with migraine with aura and hemiplegic migraine. Cephalalgia 20:1, 45-50
    CrossRef

  171. 171

    Wilmer L. Sibbitt Jr., Randy R. Sibbitt, William M. Brooks. (1999) Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis & Rheumatism 42:10, 2026-2038
    CrossRef

  172. 172

    M. Kallela, M. Wessman, M. Färkkilä, A. Palotie, M. Koskenvuo, M.-L. Honkasalo, J. Kaprio. (1999) Clinical characteristics of migraine concordant monozygotic twin pairs. Acta Neurologica Scandinavica 100:4, 254-259
    CrossRef

  173. 173

    Anne Aubertin, Michèle Fabre-Thorpe, Nelly Fabre, Gilles Géraud. (1999) Catégorisation visuelle rapide et vitesse de traitement chez le migraineux. Comptes Rendus de l'Académie des Sciences - Series III - Sciences de la Vie 322:8, 695-704
    CrossRef

  174. 174

    F. Michael Cutrer, Amy OʼDonnell. (1999) Recent advances in functional neuroimaging. Current Opinion in Neurology 12:3, 255-259
    CrossRef

  175. 175

    Arne May, Peter J. Goadsby. (1999) The Trigeminovascular System in Humans: Pathophysiologic Implications for Primary Headache Syndromes of the Neural Influences on the Cerebral Circulation. Journal of Cerebral Blood Flow & Metabolism115-127
    CrossRef

  176. 176

    E Ruppin. (1999) Pathogenic mechanisms in ischemic damage: a computational study. Computers in Biology and Medicine 29:1, 39-59
    CrossRef

  177. 177

    Marco Iacoboni, Jean-Claude Baron, Richard S.J Frackowiak, John C Mazziotta, Gian Luigi Lenzi. (1999) Emission tomography contribution to clinical neurology. Clinical Neurophysiology 110:1, 2-23
    CrossRef

  178. 178

    Andrew Charles. (1998) Intercellular calcium waves in glia. Glia 24:1, 39-49
    CrossRef

  179. 179

    Lars Edvinsson, Peter J. Goadsby. (1998) Neuropeptides in headache. European Journal of Neurology 5:4, 329-341
    CrossRef

  180. 180

    K.M.A. Welch. (1998) Current opinions in headache pathogenesis: introduction and synthesis. Current Opinion in Neurology 11:3, 193-197
    CrossRef

  181. 181

    F. Michael Cutrer, A. Gregory Sorensen, Robert M. Weisskoff, Leif stergaard, Margarita Sanchez Del Rio, E. John Lee, Bruce R. Rosen, Michael A. Moskowitz. (1998) Perfusion-weighted imaging defects during spontaneous migrainous aura. Annals of Neurology 43:1, 25-31
    CrossRef

  182. 182

    K Shibata, M Osawa, M Iwata. (1997) Pattern reversal visual evoked potentials in classic and common migraine. Journal of the Neurological Sciences 145:2, 177-181
    CrossRef

  183. 183

    Peter J. Goadsby. (1997) CURRENT CONCEPTS OF THE PATHOPHYSIOLOGY OF MIGRAINE. Neurologic Clinics 15:1, 27-42
    CrossRef

  184. 184

    Leif Østergaard, Alma Gregory Sorensen, Kenneth K. Kwong, Robert M. Weisskoff, Carsten Gyldensted, Bruce R. Rosen. (1996) High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results. Magnetic Resonance in Medicine 36:5, 726-736
    CrossRef

  185. 185

    Peter J. Goadsby, Mikael Adner, Lars Edvinsson. (1996) Characterization of Endothelin Receptors in the Cerebral Vasculature and Their Lack of Effect on Spreading Depression. Journal of Cerebral Blood Flow & Metabolism698-704
    CrossRef

  186. 186

    Masahiro Kobari. (1996) Xe/CT CBF measurements during migraine and cluster headache. Acta Neurologica Scandinavica 93, 150-151
    CrossRef

  187. 187

    Norman Tepley, Ranjith S. Wijesinghe. (1996) A dipole model for Spreading Cortical Depression. Brain Topography 8:4, 345-353
    CrossRef

  188. 188

    Ann C. McNeal. (1996) Clinical Image. MRI During Migraine with Aura. Journal of Computer Assisted Tomography 20:2, 228
    CrossRef

  189. 189

    J Schoenen. (1996) Deficient habituation of evoked cortical potentials in migraine: a link between brain biology, behavior and trigeminovascular activation?. Biomedicine & Pharmacotherapy 50:2, 71-78
    CrossRef

  190. 190

    L Friberg. (1995) Reply to Letter by V.K. Gupta-rCBF and migraine. European Journal of Neurology 2:6, 588-589
    CrossRef

  191. 191

    M. G. Buzzi, M. G. Pellegrino, P. Bellantonio. (1995) Causes and mechanisms of primary headaches: toward a bio-behavioral model. The Italian Journal of Neurological Sciences 16:9, 15-19
    CrossRef

  192. 192

    L.L. Thomsen. (1995) Arterial mechanisms in the pathophysiology of migraine headache-implications for modern therapy. European Journal of Neurology 2:5, 403-415
    CrossRef

  193. 193

    Hideaki Hara, Tominori Morita, Takayuki Sukamoto, F. Michael Cutrer. (1995) Lomerizine (KB-2796), a New Antimigraine Drug. CNS Drug Reviews 1:2, 204-226
    CrossRef

  194. 194

    C. Weiller, A. May, V. Limmroth, M. Jüptner, H. Kaube, R.V. Schayck, H.H. Coenen, H.C. Dlener. (1995) Brain stem activation in spontaneous human migraine attacks. Nature Medicine 1:7, 658-660
    CrossRef

  195. 195

    (1995) Spreading Cerebral Hypoperfusion during Migraine Headache. New England Journal of Medicine 332:22, 1516-1518
    Full Text

  196. 196

    M.D. Ferrari, P.R. Saxena. (1995) 5-HT1 receptors in migraine pathophysiology and treatment. European Journal of Neurology 2:1, 5-21
    CrossRef

  197. 197

    Olesen, Jes, . (1994) Understanding the Biologic Basis of Migraine. New England Journal of Medicine 331:25, 1713-1714
    Full Text

Letters